ClinicalTrials.Veeva

Menu

Post-Stroke Sensory Reweighting on Walking and Balance Outcomes (PSR)

University of Cincinnati logo

University of Cincinnati

Status

Enrolling

Conditions

Ischemic Stroke

Treatments

Diagnostic Test: Walking Speed
Diagnostic Test: Instrumented 7M Timed UP and GO
Diagnostic Test: Posturography
Other: Fall Event Records
Diagnostic Test: MRI (3T)

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT06727097
1R21HD115776-01 (U.S. NIH Grant/Contract)
2024-0585

Details and patient eligibility

About

The primary objective of this proof-of-concept study is to longitudinally track the development of post-stroke sensory reweighting (PSR), identify associated structural neuroanatomical correlates, and investigate their relationship to walking and fall outcomes.

Full description

Post-stroke imbalance and walking impairment is a function of diminished sensorimotor integration, motor, and postural control. It impacts over 75% of stroke survivors, and remain a rising cause of falls, fractures, and death in the United States. The associated fear of falling often leads to a downward spiral of health, characterized by reduced walking performance, caregiver dependency, social isolation, and the development of secondary post-stroke medical complications. Although spontaneous biological recovery and intensive clinical rehabilitation may improve balance and walking ability, the extent of recovery is often limited after the first 6-months of stroke (chronic phase). Furthermore, currently available clinical measures such as the Berg Balance Scale and Timed-Up-and-Go lack the specificity and granularity needed to foster the development of individualized and targeted neurorehabilitation interventions. In addition, non-invasive neurostimulation strategies lack specificity due to limited understanding of the most appropriate neuroanatomical targets for optimizing sensorimotor integration. Hence there is an urgent need to identify reliable physiologic and neuroanatomic correlates in the earlier stages of recovery (<6 months), to enable timely and targeted rehabilitation interventions.

Enrollment

45 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. First ever clinical stroke
  2. Stroke due to ischemia
  3. Age 18 years or older
  4. Ability to consent by patient (not surrogate), any time prior to acute hospital discharge

Exclusion criteria

  1. Pre-stroke dependence (modified Rankin Scale score of 3 or more)
  2. Isolated brainstem or cerebellar stroke
  3. Bilateral acute strokes
  4. Co-enrollment in a trial of an intervention through six-month follow-up
  5. Inability to maintain follow-up with study procedures through six-month follow-up
  6. Contraindication to non-contrast MRI
  7. Low likelihood of survival beyond the acute hospitalization, such as malignant cerebral edema
  8. Pre-existing co-morbid conditions that significantly affects vision, somatosensory function, vestibular system, orthostasis, coordination or mobility
  9. Post stroke mRS>4 or discharge to hospice

Trial design

45 participants in 1 patient group

Stroke Survivors
Description:
First ever clinical stroke (ischemic, supratentorial, and unilateral)
Treatment:
Diagnostic Test: MRI (3T)
Other: Fall Event Records
Diagnostic Test: Instrumented 7M Timed UP and GO
Diagnostic Test: Posturography
Diagnostic Test: Walking Speed

Trial contacts and locations

1

Loading...

Central trial contact

oluwole Awosika, MD, MSCR; Colin Drury, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems